{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:55:06Z","timestamp":1791312906878,"version":"4.3.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"JSPS","award":["16H05323"],"award-info":[{"award-number":["16H05323"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.jneuroim.2016.08.012","type":"journal-article","created":{"date-parts":[[2016,8,13]],"date-time":"2016-08-13T03:26:13Z","timestamp":1471058773000},"page":"51-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["HTLV-1 induces a Th1-like state in CD4+CCR4+ T cells that produces an inflammatory positive feedback loop via astrocytes in HAM\/TSP"],"prefix":"10.1016","volume":"304","author":[{"given":"Yoshihisa","family":"Yamano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariella","family":"Coler-Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2016.08.012_bb0005","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1093\/brain\/awt183","article-title":"Positive feedback loop via astrocytes causes chronic inflammation in virus-associated myelopathy","volume":"136","author":"Ando","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0010","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.3390\/v3091532","article-title":"Human T-lymphotropic virus type 1 (HTLV-1) and regulatory T cells in HTLV-1-associated neuroinflammatory disease","volume":"3","author":"Araya","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0015","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1172\/JCI75250","article-title":"HTLV-1 induces a Th1-like state in CD4+CCR4+ T cells","volume":"124","author":"Araya","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0020","first-page":"1","article-title":"HTLV-I-associated myelopathy\/tropical spastic paraparesis","volume":"1","author":"Bangham","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/sj.onc.1201906","article-title":"Persistent oligoclonal expansion of human T-cell leukemia virus type 1-infected circulating cells in patients with tropical spastic paraparesis\/HTLV-1 associated myelopathy","volume":"17","author":"Cavrois","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0030","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/med.21281","article-title":"A cutting-edge view on the current state of antiviral drug development","volume":"33","author":"De Clercq","year":"2013","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0035","first-page":"228","article-title":"Heightened transmigrating activity of CD4-positive T cells through reconstituted basement membrane in patients with human T-lymphotropic virus type I-associated myelopathy","volume":"109","author":"Furuya","year":"1997","journal-title":"Proc. Assoc. Am. Physicians"},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0040","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","article-title":"Epidemiological aspects and world distribution of HTLV-1 infection","volume":"3","author":"Gessain","year":"2012","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0045","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","article-title":"Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis","volume":"2","author":"Gessain","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0050","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1182\/blood.V98.3.721","article-title":"High production of interferon gamma but not interleukin-2 by human T-lymphotropic virus type I-infected peripheral blood mononuclear cells","volume":"98","author":"Hanon","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0055","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1200\/JCO.2011.37.3472","article-title":"Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study","volume":"30","author":"Ishida","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0060","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1158\/1078-0432.CCR-09-2697","article-title":"Defucosylated humanized anti-CCR4 monoclonal antibody KW-0761 as a novel immunotherapeutic agent for adult T-cell leukemia\/lymphoma","volume":"16","author":"Ishii","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0065","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1442-200X.1992.tb00972.x","article-title":"Neuropathology of HTLV-I-associated myelopathy-a report of two autopsy cases","volume":"34","author":"Izumo","year":"1992","journal-title":"Acta Paediatr. Jpn."},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0070","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1212\/WNL.46.4.1016","article-title":"Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicenter, randomized, double-blind, controlled trial","volume":"46","author":"Izumo","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0075","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2141.2004.04999.x","article-title":"Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia\/lymphoma cells","volume":"126","author":"Karube","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0080","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0165-5728(99)00175-7","article-title":"HTLV-I specific IFN-gamma+CD8+ lymphocytes correlate with the proviral load in peripheral blood of infected individuals","volume":"102","author":"Kubota","year":"2000","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0085","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.autrev.2008.12.002","article-title":"CXCL10 and autoimmune diseases","volume":"8","author":"Lee","year":"2009","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0090","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3390\/v3050469","article-title":"Susceptibility of primary HTLV-1 isolates from patients with HTLV-1-associated myelopathy to reverse transcriptase inhibitors","volume":"3","author":"Macchi","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0095","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s004010050903","article-title":"Perivascular T cells are infected with HTLV-I in the spinal cord lesions with HTLV-I-associated myelopathy\/tropical spastic paraparesis: double staining of immunohistochemistry and polymerase chain reaction in situ hybridization","volume":"96","author":"Matsuoka","year":"1998","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0100","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/NEN.0000000000000141","article-title":"Visualization of HTLV-1-specific cytotoxic T lymphocytes in the spinal cords of patients with HTLV-1-associated myelopathy\/tropical spastic paraparesis","volume":"74","author":"Matsuura","year":"2015","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0105","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/13550289909015810","article-title":"Detection of human T-lymphotropic virus type I p40tax protein in cerebrospinal fluid cells from patients with human T-lymphotropic virus type I-associated myelopathy\/tropical spastic paraparesis","volume":"5","author":"Moritoyo","year":"1999","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0110","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/ni.1899","article-title":"Effector T cell plasticity: flexibility in the face of changing circumstances","volume":"11","author":"Murphy","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0115","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3109\/13550289809114225","article-title":"Analysis of HTLV-I proviral load in 202 HAM\/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM\/TSP","volume":"4","author":"Nagai","year":"1998","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0120","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/ana.10065","article-title":"Increased HTLV-I proviral load and preferential expansion of HTLV-I tax-specific CD8+ T cells in cerebrospinal fluid from patients with HAM\/TSP","volume":"50","author":"Nagai","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0125","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/13550289609146899","article-title":"Therapeutic trials in 200 patients with HTLV-I-associated myelopathy\/tropical spastic paraparesis","volume":"2","author":"Nakagawa","year":"1996","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0130","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1158\/0008-5472.CAN-03-2068","article-title":"Defucosylated chimeric anti-CC chemokine receptor 4 IgG1 with enhanced antibody-dependent cellular cytotoxicity shows potent therapeutic activity to T-cell leukemia and lymphoma","volume":"64","author":"Niwa","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0135","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jns.2005.05.010","article-title":"HTLV-1 proviral load in peripheral blood mononuclear cells quantified in 100 HAM\/TSP patients: a marker of disease progression","volume":"237","author":"Olindo","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0140","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","article-title":"HTLV-I associated myelopathy, a new clinical entity","volume":"1","author":"Osame","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0145","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1172\/JCI1422","article-title":"The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions","volume":"101","author":"Qin","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0150","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.1128\/jvi.64.11.5682-5687.1990","article-title":"In vivo cellular tropism of human T-cell leukemia virus type 1","volume":"64","author":"Richardson","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0155","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1084\/jem.187.6.875","article-title":"Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes","volume":"187","author":"Sallusto","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002479","article-title":"CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy\/tropical spastic paraparesis","volume":"7","author":"Sato","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0165","doi-asserted-by":"crossref","first-page":"17945","DOI":"10.1073\/pnas.1316796110","article-title":"Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans","volume":"110","author":"Sugiyama","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0170","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1742-4690-3-63","article-title":"Zidovudine plus lamivudine in human T-lymphotropic virus type-l-associated myelopathy: a randomised trial","volume":"3","author":"Taylor","year":"2006","journal-title":"Retrovirology"},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0175","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4049\/jimmunol.0903846","article-title":"Human T-lymphotropic virus type 1-induced CC chemokine ligand 22 maintains a high frequency of functional FoxP3+ regulatory T cells","volume":"185","author":"Toulza","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0180","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.V50.3.481.481","article-title":"Adult T-cell leukemia: clinical and hematologic features of 16 cases","volume":"50","author":"Uchiyama","year":"1977","journal-title":"Blood"},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0185","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/00005072-199401000-00009","article-title":"Cytokine expression in the spinal cord lesions in HTLV-I-associated myelopathy","volume":"53","author":"Umehara","year":"1994","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0190","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1128\/jvi.69.5.2863-2868.1995","article-title":"Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy","volume":"69","author":"Wattel","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006517","article-title":"Abnormally high levels of virus-infected IFN-\u03b3+ CCR4+ CD4+ CD25+ T cells in a retrovirus-associated neuroinflammatory disorder","volume":"4","author":"Yamano","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0200","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/infdis\/jiu438","article-title":"Mogamulizumab, an anti-CCR4 antibody, targets human T-lymphotropic virus type 1-infected CD8+ and CD4+ T cells to treat associated myelopathy","volume":"211","author":"Yamauchi","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2016.08.012_bb0205","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1182\/blood.V99.5.1505","article-title":"Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells","volume":"99","author":"Yoshie","year":"2002","journal-title":"Blood"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572816301941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572816301941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:28:32Z","timestamp":1759048112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572816301941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":41,"alternative-id":["S0165572816301941"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2016.08.012","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HTLV-1 induces a Th1-like state in CD4+CCR4+ T cells that produces an inflammatory positive feedback loop via astrocytes in HAM\/TSP","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2016.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}